
|Articles|September 22, 2020
Women with DCIS at higher risk of death from breast cancer
Author(s)Lindsey Carr, Editor
According to new research, women with ductal carcinoma in situ (DCIS) are more than three times as likely to suffer from breast cancer mortality than women in the general population.
Advertisement
Researchers from the University of Toronto conducted a study, published in JAMA Network Open, that investigated the actual risk of death associated with DCIS in women with a DCIS diagnosis between 1995 and 2014.
“In the population studied, the risk of dying of breast cancer…suggests that our current treatment focus on preventing invasive recurrence is insufficient to eliminate all deaths from breast cancer after DCIS,” said the team led by Vasily Giannakeas, MPH, a doctoral candidate at the University of Toronto and Women’s College Research Institute.
Read more about the findings and their implications on Diagnostic Imaging .
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients
2
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
3
Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals
4
HIV screening, PrEP counseling get stronger ACOG recommendation
5





